Your browser doesn't support javascript.
loading
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Curtis, Lauren M; Ostojic, Alen; Venzon, David J; Holtzman, Noa G; Pirsl, Filip; Kuzmina, Zoya J; Baird, Kristin; Rose, Jeremy J; Cowen, Edward W; Mays, Jacqueline W; Mitchell, Sandra A; Parsons-Wandell, Laura; Joe, Galen O; Comis, Leora E; Berger, Ann; Pusic, Iskra; Peer, Cody J; Figg, William D; Cao, Liang; Gale, Robert Peter; Hakim, Frances T; Pavletic, Steven Z.
Afiliación
  • Curtis LM; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Ostojic A; Sibley Memorial Hospital, Sidney Kimmel Cancer Center, Johns Hopkins Medicine, Washington, DC.
  • Venzon DJ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Holtzman NG; Division for Hematology, Department for Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
  • Pirsl F; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Kuzmina ZJ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Baird K; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Rose JJ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Cowen EW; Wilhelminen Hospital, Vienna, Austria.
  • Mays JW; Pediatric Oncology Branch and.
  • Mitchell SA; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Parsons-Wandell L; Dermatology Branch, National Institute for Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD.
  • Joe GO; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.
  • Comis LE; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Berger A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Pusic I; Department of Rehabilitation Medicine, and.
  • Peer CJ; Department of Rehabilitation Medicine, and.
  • Figg WD; Department of Pain and Palliative Care, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Cao L; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
  • Gale RP; Clinical Pharmacology Program and.
  • Hakim FT; Clinical Pharmacology Program and.
  • Pavletic SZ; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.
Blood ; 137(7): 896-907, 2021 02 18.
Article en En | MEDLINE | ID: mdl-32976576
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Terapia Recuperativa / Enfermedad Injerto contra Huésped / Factores Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Moldova
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Talidomida / Terapia Recuperativa / Enfermedad Injerto contra Huésped / Factores Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article País de afiliación: Moldova